Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology
Authors:
- Sarah M. RothmanSarah M. Rothman
- Keith Q. TanisKeith Q. Tanis
- Pallavi GandhiPallavi Gandhi
- Vladislav MalkovVladislav Malkov
- Jacob MarcusJacob Marcus
- Michelle PearsonMichelle Pearson
- Richard StevensRichard Stevens
- Jason GillilandJason Gilliland
- Christopher WareChristopher Ware
- Veeravan MahadomrongkulVeeravan Mahadomrongkul
- Elaine O’loughlinElaine O’loughlin
- Gonzalo ZeballosGonzalo Zeballos
Open Access
- 6 September 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 15 (1) , 1-15
Abstract
Alzheimer’s disease (AD) is a chronic neurodegenerative disease with pathological hallmarks including the formation of extracellular aggregates of amyloid-beta (Aβ) known as plaques and intracellular tau tangles. Coincident with the formation of Aβ plaques is recruitment and activation of glial cells to the plaque forming a plaque niche. In addition to histological data showing the formation of the niche, AD genetic studies have added to the growing appreciation of how dysfunctional glia pathways drive neuropathology, with emphasis on microglia pathways. Genomic approaches enable comparisons of human disease profiles between different mouse models informing on their utility to evaluate secondary changes to triggers such as Aβ deposition. In this study, we utilized two animal models of AD to examine and characterize the AD-associated pathology: the Tg2576 Swedish APP (KM670/671NL) and TgCRND8 Swedish plus Indiana APP (KM670/671NL + V717F) lines. We used laser capture microscopy (LCM) to isolate samples surrounding Thio-S positive plaques from distal non-plaque tissue. These samples were then analyzed using RNA sequencing. We determined age-associated transcriptomic differences between two similar yet distinct APP transgenic mouse models, known to differ in proportional amyloidogenic species and plaque deposition rates. In Tg2576, human AD gene signatures were not observed despite profiling mice out to 15 months of age. TgCRND8 mice however showed progressive and robust induction of lysomal, neuroimmune, and ITIM/ITAM-associated gene signatures overlapping with prior human AD brain transcriptomic studies. Notably, RNAseq analyses highlighted the vast majority of transcriptional changes observed in aging TgCRND8 cortical brain homogenates were in fact specifically enriched within the plaque niche samples. Data uncovered plaque-associated enrichment of microglia-related genes such as ITIM/ITAM-associated genes and pathway markers of phagocytosis. This work may help guide improved translational value of APP mouse models of AD, particularly for strategies aimed at targeting neuroimmune and neurodegenerative pathways, by demonstrating that TgCRND8 more closely recapitulates specific human AD-associated transcriptional responses.Keywords
This publication has 69 references indexed in Scilit:
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid BetaNeuron, 2013
- Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal AgingPLOS ONE, 2011
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratioThe EMBO Journal, 2010
- Unravelling mononuclear phagocyte heterogeneityNature Reviews Immunology, 2010
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Microglial C5aR (CD88) expression correlates with amyloid‐β deposition in murine models of Alzheimer’s diseaseJournal of Neurochemistry, 2010
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled TrialJAMA, 2009
- The Ratio of Monomeric to Aggregated Forms of Aβ40 and Aβ42 Is an Important Determinant of Amyloid-β Aggregation, Fibrillogenesis, and ToxicityJournal of Biological Chemistry, 2008